Quantum Genesis AI Corp. (OTC: QGAI) announced today that the Caveat Emptor designation previously applied to its securities by OTC Markets Group has been removed. The company worked cooperatively with OTC Markets to provide information and respond to inquiries during the review process.
"We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation," said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. "Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement. We thank OTC Markets for their professionalism and assistance, and we remain committed to maintaining open communication with our shareholders and the marketplace."
The removal of the Caveat Emptor designation is significant for investors as it signals that the company has resolved the concerns that led to the designation. Caveat Emptor, meaning "let the buyer beware," is applied by OTC Markets when there are concerns about the accuracy of information or other issues that may affect investor protection. The removal typically indicates that the company has provided sufficient information to address those concerns.
Quantum Genesis AI continues to advance its strategic initiatives in artificial intelligence, computational modeling, and scientific innovation. The company remains committed to responsible corporate governance and public company compliance. This development may enhance the company's ability to attract investors and partners, as the removal of the designation improves the company's standing in the financial community.
For more information, visit www.qgaicorp.com and the company's profile at www.otcmarkets.com/stock/QGAI.
